The increasing demand for controlled immunological study and therapeutic design has spurred significant progress in recombinant cytokine manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using multiple expression systems, including bacterial hosts, mammalian cell cultures, and viral expre